Rational design of boropeptide thrombin inhibitors: β,β-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profile
- 1 February 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (3) , 301-306
- https://doi.org/10.1016/s0960-894x(98)00013-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- (N-acyl-N-alkyl)glycyl borolysine analogs: A new class of potent thrombin inhibitorsBioorganic & Medicinal Chemistry Letters, 1996
- Thrombin active site inhibitorsBioorganic & Medicinal Chemistry, 1995
- Synthesis of Thrombin Inhibitor DuP 714The Journal of Organic Chemistry, 1995
- Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structuresBiochemical Journal, 1993
- Structure of Human Des(1-45) Factor Xa at 2·2 Å ResolutionJournal of Molecular Biology, 1993
- The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationshipsProtein Science, 1992
- The selective inhibition of thrombin by peptides of boroarginine.Journal of Biological Chemistry, 1990
- Aromatic-Aromatic Interaction: A Mechanism of Protein Structure StabilizationScience, 1985
- Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and IBiochemistry, 1983
- Degranulation and Histamine Release, Two Consecutive Steps in the Response of Rat Mast Cells to Compound 48/80Acta Physiologica Scandinavica, 1967